Healthspan Extension
Extend the years lived in health, strength, and clarity
The goal is to extend healthspan — the years lived in health, not merely lifespan — by treating the underlying processes of aging so that age-related decline is delayed and more of life is lived strong, sharp, and independent.
For most of history aging was treated as an untouchable given. Modern biology sees it as a set of specific, measurable processes — senescent cells, chronic inflammation, failing mitochondria, exhausted stem cells, molecular damage. Crucially, the diseases of aging share these roots, so addressing aging itself could delay many diseases at once. Extending the healthy years — more time vital rather than frail — may be the highest-leverage goal in medicine. That is why healthspan extension is the flagship of longevity. It is also a hype-prone field, so we hold it to a high evidence bar.
We are building the capability to slow and partly reverse the drivers of aging: clearing aged cells, calming chronic inflammation, restoring mitochondria and stem-cell pools, and measuring biological age so interventions can be guided — all aimed at adding healthy, functional years.
Targeting the shared roots of age-related disease
Clearing senescent cells In human trials
Aged senescent cells accumulate and poison surrounding tissue; drugs called senolytics clear them and reversed multiple signs of aging in animals — now in human trials.
Measuring biological age Demonstrated
“Epigenetic clocks” can measure how fast a person is biologically aging — turning aging into something trackable and targetable.
Renewing tired tissues Frontier
Rejuvenating aged stem cells, restoring mitochondria, and reviving cellular clean-up systems aim to renew the body’s own repair capacity.
Reprogramming cellular age Frontier
Partial cellular reprogramming has reversed signs of age in cells and tissues in the lab — striking, and carefully watched.
Cited as evidence the capability is real — not as partners or endorsers.
Universities & institutes
Academic geroscience, aging-biology, and longevity research centers studying senescence, epigenetic clocks, and reprogramming.
Government & programs
National Institute on Aging (NIA, NIH) · NIH geroscience programs · ARPA-H.
Enabling science base
senolytics & senescence biology · epigenetic clocks · mitochondrial & stem-cell aging · partial reprogramming · inflammaging research.
The technologies: senolytics that clear aged cells; epigenetic clocks that measure biological age; stem-cell and mitochondrial rejuvenation; partial reprogramming that resets cellular age in the lab; and anti-inflammaging approaches that calm the chronic inflammation of aging.
Senolytics in human trials Clinical — trials
Senolytic drugs that clear senescent cells reversed signs of aging in animals and are now in human trials.
Biological-age measurement Demonstrated
Epigenetic clocks reliably measure biological aging rate. Stage: Demonstrated.
Cellular reprogramming Frontier
Partial reprogramming reversed age markers in cells and tissues in the lab — a closely-watched frontier.
Stem-cell & mitochondrial renewal Frontier
Rejuvenating stem cells and mitochondria is advancing in research.
The honest challenges, held to a high bar because this field attracts hype: most interventions are demonstrated in animals or early trials, not proven to extend healthy human life yet. Aging is multi-causal — no single therapy addresses all of it. Reprogramming is striking but carries real risks (including cancer) and is far from the clinic. And outcomes must be measured over long timeframes. What is real: senolytic trials and biological-age measurement. What is frontier: rejuvenation and reprogramming. We will not overstate it.
The future, fully built
A person facing the decline of age has the drivers of aging slowed and turned back: senescent cells cleared, inflammation calmed, tissues renewed — so more of life is lived in strength, clarity, and independence, with the diseases of aging pushed back. Aging becomes something we actively address, honestly and carefully.
The proof, for this capability
Cited as evidence the capability is real, not as partners or endorsers.
Senolytics
Drugs that clear senescent cells reversed aging signs in animals and are in human trials. Stage: Clinical (trials).
Epigenetic clocks
Measure biological aging rate reliably. Stage: Demonstrated.
Partial reprogramming
Reversed age markers in cells/tissues in the lab; carries risks; far from clinic. Stage: Frontier.
Honest framing
Real organizations are cited as evidence the capability is real — not as partners or endorsers. No therapy is proven to extend healthy human life yet; we do not claim one is.
Help build this future
Every signature grows the movement to make healthy longevity real — and free at the point of need.